Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

Roger Stupp*, Monika E. Hegi, Bart Neyns, Roland Goldbrunner, Uwe Schlegel, Paul M J Clement, Gerhard G. Grabenbauer, Adrian F. Ochsenbein, Matthias Simon, Pierre Yves Dietrich, Torsten Pietsch, Christine Hicking, Joerg Christian Tonn, Annie Claire Diserens, Alessia Pica, Mirjam Hermisson, Stefan Krueger, Martin Picard, Michael Weller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

365 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science